Department of Cardiology, Faculty of Medicine, University of Tsukuba, Japan (Y.K., A.N., K.A., M.I.).
Bordeaux University Hospital (Centre Hospitalier Universitaire [CHU]), Electrophysiology and Ablation Unit, Pessac, France (M.H., A.D., M.H.).
Circulation. 2019 May 14;139(20):2315-2325. doi: 10.1161/CIRCULATIONAHA.118.037997.
Ventricular fibrillation (VF) storm after myocardial infarction (MI) is a life-threatening condition that necessitates multiple defibrillations. Catheter ablation is a potentially effective treatment strategy for VF storm refractory to optimal medical treatment. However, its impact on patient survival has not been verified in a large population.
We conducted a multicenter, retrospective observational study involving consecutive patients who underwent catheter ablation of post-MI refractory VF storm without preceding monomorphic ventricular tachycardia. The target of ablation was the Purkinje-related ventricular extrasystoles triggering VF. The primary outcome was in-hospital and long-term mortalities. Univariate logistic regression and Cox proportional-hazards analysis were used to evaluate clinical characteristics associated with in-hospital and long-term mortalities, respectively.
One hundred ten patients were enrolled (age, 65±11years; 92 men; left ventricular ejection fraction, 31±10%). VF storm occurred at the acute phase of MI (4.5±2.5 days after the onset of MI during the index hospitalization for MI) in 43 patients (39%), the subacute phase (>1 week) in 48 (44%), and the remote phase (>6 months) in 19 (17%). The focal triggers were found to originate from the scar border zone in 88 patients (80%). During in-hospital stay after ablation, VF storm subsided in 92 patients (84%). Overall, 30 (27%) in-hospital deaths occurred. The duration from the VF occurrence to the ablation procedure was associated with in-hospital mortality (odds ratio for each 1-day increase, 1.11 [95% CI, 1.03-1.20]; P=0.008). During follow-up after discharge from hospital, only 1 patient developed recurrent VF storm. However, 29 patients (36%) died, with a median survival time of 2.2 years (interquartile range, 1.2-5.5 years). Long-term mortality was associated with left ventricular ejection fraction <30% (hazard ratio, 2.54 [95% CI, 1.21-5.32]; P=0.014), New York Heart Association class ≥III (hazard ratio, 2.68 [95% CI, 1.16-6.19]; P=0.021), a history of atrial fibrillation (hazard ratio, 3.89 [95% CI, 1.42-10.67]; P=0.008), and chronic kidney disease (hazard ratio, 2.74 [95% CI, 1.15-6.49]; P=0.023).
In patients with MI presenting with focally triggered VF storm, catheter ablation of culprit triggers is lifesaving and appears to be associated with short- and long-term freedom from recurrent VF storm. Mortality over the long-term follow-up is associated with the severity of underlying cardiovascular disease and comorbidities in this specific patient population.
心肌梗死后(MI)室颤(VF)风暴是一种危及生命的情况,需要多次除颤。导管消融是一种对最佳药物治疗无效的 VF 风暴的潜在有效治疗策略。然而,其对患者生存的影响尚未在大规模人群中得到证实。
我们进行了一项多中心、回顾性观察性研究,纳入了连续接受 MI 后药物难治性 VF 风暴导管消融的患者,且无先前的单形性室性心动过速。消融的靶点是触发 VF 的浦肯野纤维相关室性早搏。主要结局是院内和长期死亡率。单变量逻辑回归和 Cox 比例风险分析分别用于评估与院内和长期死亡率相关的临床特征。
共纳入 110 例患者(年龄 65±11 岁;92 例男性;左心室射血分数 31±10%)。VF 风暴发生在 MI 的急性期(MI 发病后 4.5±2.5 天,在 MI 的索引住院期间)43 例(39%)、亚急性期(>1 周)48 例(44%)和恢复期(>6 个月)19 例(17%)。发现焦点触发源起源于瘢痕边界区 88 例(80%)。消融后住院期间,92 例(84%)患者 VF 风暴缓解。总体而言,30 例(27%)患者发生院内死亡。VF 发生到消融程序的时间与院内死亡率相关(每增加 1 天的优势比,1.11[95%CI,1.03-1.20];P=0.008)。出院后随访期间,仅 1 例患者出现复发性 VF 风暴。然而,29 例(36%)患者死亡,中位生存时间为 2.2 年(四分位距,1.2-5.5 年)。长期死亡率与左心室射血分数<30%(风险比,2.54[95%CI,1.21-5.32];P=0.014)、纽约心脏协会(NYHA)分级≥III 级(风险比,2.68[95%CI,1.16-6.19];P=0.021)、房颤病史(风险比,3.89[95%CI,1.42-10.67];P=0.008)和慢性肾脏病(风险比,2.74[95%CI,1.15-6.49];P=0.023)相关。
在 MI 患者中,导管消融导致的 VF 风暴的触发灶是救生的,并与短期和长期无复发性 VF 风暴相关。在这一特定患者人群中,长期随访的死亡率与潜在心血管疾病的严重程度和合并症相关。